{{Rsnum
|rsid=7704909
|Chromosome=5
|position=25898812
|Orientation=plus
|GMAF=0.2392
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 12.4 | 50.4 | 37.2
| HCB | 3.6 | 22.6 | 73.7
| JPT | 0.9 | 24.8 | 74.3
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 10.5 | 89.5
| CHB | 3.6 | 22.6 | 73.7
| CHD | 0.9 | 25.9 | 73.1
| GIH | 17.8 | 45.5 | 36.6
| LWK | 0.0 | 0.9 | 99.1
| MEX | 12.1 | 39.7 | 48.3
| MKK | 2.6 | 25.6 | 71.8
| TSI | 15.7 | 52.0 | 32.4
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs7704909
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19404256
|Annotation=This SNP on 5p14.1 was associated with autism spectrum disorder in a combined analysis of four GWAS data sets with a total of more than 10,000 subjects of European ancestry. This SNP is in an intergenic region between CDH10 and CDH9 that contains several highly conserved genomic elements.
|Drugs=
|Drug Classes=
|Diseases=Autism Spectrum Disorder
|Curation Level=Curated
|PharmGKB Accession ID=PA164741096
}}

{{PMID Auto
|PMID=19456320
|Title=A genome-wide association study of autism reveals a common novel risk locus at 5p14.1.
|OA=1
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs7704909
|overall_frequency_n=28
|overall_frequency_d=122
|overall_frequency=0.229508
|n_genomes=18
|n_genomes_annotated=0
|n_haplomes=21
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}